Spasticity: Clinical Trials

4 trials for Spasticity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 4

Follow Spasticity: new trials by email Literature Review of Spasticity trials Research Report on Spasticity

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Imaging of 3D Innervation Zone Distribution in Spastic Muscles From High-density Surface EMG Recordings
Botulinum neurotoxin (BTX), Physical Therapy, Standard BTX injection (ultrasound guided) - Spasticity
Phase 4CompletedThe University of Texas Health Science Center, Houston172017-11-212020-11-05
A Randomized Study of Sativex on Cognitive Function and Mood: Multiple Sclerosis Patients
Sativex, Placebo - Multiple Sclerosis, Spasticity
Phase 4CompletedJazz Pharmaceuticals1212012-01-012023-01-12
Vanderbilt University Spasticity Management Program Evaluation Plan
Botulinum Toxin Type A, Intrathecal baclofen administered by the Medtronic SyncroMed(TM) pump (ITB) - Spasticity
Phase 4CompletedVanderbilt University202002-08-012007-08-20
Comparative Efficacy of Three Preparations of Botox-A in Treating Spasticity
Botox - Stroke, Brain Injuries
Phase 4CompletedThe University of Texas Health Science Center, Houston332002-01-012021-01-22

Narrower conditions

Muscle Spasticity (4)  ·  Stroke (2)  ·  Brain Injuries (1)  ·  Developmental Disabilities (1)  ·  Multiple Sclerosis (1)

Broader conditions

Muscle Hypertonia (4)  ·  Muscular Diseases (4)  ·  Musculoskeletal Diseases (4)  ·  Nervous System Diseases (4)  ·  Neurologic Manifestations (4)  ·  Neuromuscular Manifestations (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Signs and Symptoms (4)  ·  Brain Diseases (2)  ·  Cardiovascular Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Cerebrovascular Disorders (2)  ·  Vascular Diseases (2)  ·  Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)

Interventions

Botulinum Toxins, Type A (3)  ·  Botulinum Toxins (1)  ·  Physical Therapy Modalities (1)  ·  nabiximols (1)

Sponsors

The University of Texas Health Science Center, Houston (2)  ·  Jazz Pharmaceuticals (1)  ·  Vanderbilt University (1)

Countries

United States (3)  ·  Czechia (1)

Top investigators

David Charles, MD (1)  ·  Gerard E Francisco, MD (1)  ·  Sheng Li, MD, PhD (1)

Results publications

PMID 24151639, PMID 34532852